Kyung Hee Jung
Overview
Explore the profile of Kyung Hee Jung including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
111
Citations
1436
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Jeon B, Lee Y, Shin J, Choi M, Lee C, Son M, et al.
Am J Cancer Res
. 2023 Mar;
13(2):452-463.
PMID: 36895970
Double hit diffuse large B-cell lymphoma (DLBCL) with rearrangement and overexpression of both c-Myc and Bcl-2 responds poorly to standard R-CHOP therapy. In a recent phase I study, Venetoclax (ABT-199)...
12.
Oh S, Jo S, Kim H, Mai V, Endaya B, Neuzil J, et al.
Anal Chem
. 2023 Jan;
95(2):1184-1192.
PMID: 36602057
Early diagnosis of hepatocellular carcinoma (HCC) is difficult; the lack of convenient biomarker-based diagnostic modalities renders high-risk HCC patients burdened by life-long periodical examinations. Here, a new chemical biopsy approach...
13.
Ko S, Jung K, Yoon Y, Han B, Park M, Lee Y, et al.
Am J Cancer Res
. 2022 Oct;
12(9):4326-4342.
PMID: 36225647
Pancreatic ductal adenocarcinoma (PDAC) is an extracellular matrix (ECM)-rich carcinoma, which promotes chemoresistance by inhibiting drug diffusion into the tumor. Discoidin domain receptor 1 (DDR1) increases tumor progression and drug...
14.
Han B, Jung K, Lee J, Yoon Y, Ko S, Park M, et al.
Am J Cancer Res
. 2022 Aug;
12(7):3083-3098.
PMID: 35968350
The use of anesthetics in the surgical resection of tumors may influence the prognosis of cancer patients. Lidocaine, a local anesthetic, is known to act as a chemosensitizer and relieve...
15.
Seo M, Jung K, Kim K, Lee J, Han B, Ko S, et al.
Biomed Pharmacother
. 2022 Jun;
152:113241.
PMID: 35691157
The novel (nua) kinase family 1 (NUAK1) is an AMPK-related kinase and its expression is associated with tumor malignancy and poor prognosis in several types of cancer, suggesting its potential...
16.
Lee J, Kang M, Jang J, Lee J, Yang Y, Choi J, et al.
Sci Rep
. 2022 May;
12(1):8620.
PMID: 35597800
Stem cells are attractive candidates for the regeneration of tissue and organ. Mesenchymal stem cells (MSCs) have been extensively investigated for their potential applications in regenerative medicine and cell therapy....
17.
Lee J, Woo M, Jung K, Kang Y, Shin S, Son M, et al.
Biomol Ther (Seoul)
. 2021 Oct;
30(3):274-283.
PMID: 34663758
KRAS activating mutations, which are present in more than 90% of pancreatic cancers, drive tumor dependency on the RAS/mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/AKT signaling pathways. Therefore, combined...
18.
Nam H, Hong S, Jung K, Kang S, Park M, Kang S, et al.
J Natl Cancer Inst
. 2021 Oct;
114(2):228-234.
PMID: 34613397
Background: Pancreatic cancer (PC) has a grim prognosis, and an early diagnostic biomarker has been highly desired. The molecular link between diabetes and PC has not been well established. Methods:...
19.
Yan H, Jung K, Lee J, Son M, Fang Z, Park J, et al.
Cancer Lett
. 2021 Jul;
519:185-198.
PMID: 34311032
Oncogenic KRAS induces neoplastic transformation of pancreatic acinar cells through acinar-to-ductal metaplasia (ADM) and pancreatic intraepithelial neoplasia (PanIN), and drives pancreatic ductal adenocarcinoma (PDAC). Angiopoietin-like 4 (ANGPTL4) is known to...
20.
Lee J, Kang Y, Jung K, Son M, Shin S, Kim J, et al.
Cancer Lett
. 2021 Mar;
507:97-111.
PMID: 33744388
KRAS mutation is associated with the progression and growth of pancreatic cancer and contributes to chemo-resistance, which poses a significant clinical challenge in pancreatic cancer. Here, we developed a RT22-ep59...